Bionano Genomics Inc (BNGO)

Get Bionano Genomics Inc (BNGO) share price insights to refine your trading strategy. Stay updated with FP Markets for expert market trends.

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Bionano Genomics Inc (BNGO) Profile

Bionano Genomics Inc (BNGO.xnas) is a genome analysis company providing Saphyr platform with tools and services to analyse the long segments of genomic DNA headquartered in California, America. Bionano company does extensive genetic research, patient testing, and diagnosing testing for autism spectrum disorder and other neurodevelopmental disabilities and offers proprietary nanochannel chips and automated imaging instrument. Bionano’s platform Saphyr provides ultra-sensitive and ultra-specific structural variation detection that enables scientists and clinicians to accelerate the search for new diagnostics and therapeutic targets and streamline the study of chromosome changes. Bionano Genomics employs 180 people and has a market capitalisation of $1.05B (USD) as of December 2021. The Bionano Genomics Inc stock (BNGO.xnas) is listed on NASDAQ and has a $4.7M (USD) in 2021 revenue. The Bionano is the parent company of BioDiscovery and Lineagen and has 3 offices in 3 countries. Bionano Genomics Inc is making major improvements with the Saphyr platform, with a record number of Saphyr shipments and saw a big increase of 122% year-over-year in the sale of nanochannel array flow cells used with the instrument. The company released Bionano Solve version 3.7 and Bionano Access version 1.7 as available data solution upgrades for Saphyr systems installed in laboratories worldwide and as of November 2021.

Start Trading Bionano Genomics Inc (BNGO) with a Market Leader Today

Bionano Genomics Inc (BNGO) Trading FAQ

Shares represent units of ownership within a company. Shares are also known as stocks or equities. Dividend payments are common with some companies, a method of sharing company profits with shareholders. In addition to traditional share dealing, however, traders can access derivatives: trading instruments derived from the movement of an underlying share price.

Individual stock CFDs (contract for differences) fall under the umbrella of derivative products, an effective low-cost trading vehicle. While CFDs do not grant shareholder privileges, active CFD positions may receive a dividend if executed before the ex-dividend date.

Start Trading
in minutes

Get instant Updates in Telegram